Choose Adult IndicationDrugDrug name X NVAF Reduce stroke risk PAD Reduce the risk of major thrombotic vascular events CAD Reduce the risk of major CV events VTE Prophylaxis Acutely Ill Medical Patients DVT/PE Initial treatment DVT/PE Extended treatment DVT Prophylaxis After hip/knee replacement surgery Home Clinical Trial Efficacy Profile Safety Profile Dosing Home Clinical Trials Efficacy Safety Net Clinical Benefit Summary Dosing Home Clinical Trials Efficacy Profile Safety Profile Dosing Home Clinical Trials Efficacy Profile Safety Profile Dosing Home Clinical Trial Efficacy Profile Safety Profile Dosing Home Clinical Trials Efficacy Profile Safety Profile Dosing Home Clinical Trial Efficacy Profile Safety Profile Dosing Adult Dosing NVAF CAD/PAD DVT/PE Adult Switch and Management Switching to/from XARELTO® Bleed management considerations Temporary discontinuation Other administration Access and Support Janssen Select Janssen CarePath Formulary Finder Prescription Assistance Request XARELTO® samples Resources Resources Hub FAQs Pediatric VTE (Pediatrics) Post Fontan (Pediatrics) Search Important Safety Information US Prescribing Information Medication Guide For Non-US Visitors Patient Site SEARCH For Choose Adult Indication NVAFReduce stroke risk PADReduce the risk of major thrombotic vascular events CADReduce the risk of major CV events VTE ProphylaxisAcutely Ill Medical Patients DVT/PEInitial treatment DVT/PEExtended treatment DVT ProphylaxisAfter hip/knee replacement surgery
XARELTO®: Deep vein thrombosis (DVT) prophylaxis after hip or knee replacement surgery Proven efficacy and safety profile in DVT prophylaxis after hip or knee replacement surgery DVT PROPHYLAXIS DOSING Convenient, once-daily* oral dosing DVT PROPHYLAXIS EFFICACY Significantly lower rates of total VTE versus enoxaparin after hip or knee replacement surgery1-3 DVT PROPHYLAXIS SAFETY Similar rates of bleeding versus enoxaparin after hip/knee replacement surgery1-3 DVT PROPHYLAXIS CLINICAL TRIALS Time and time again—extensive clinical and real-world evidence1-4 FORMULARY FINDER Coverage for your patients JANSSEN CAREPATH XARELTO® Savings Program DVT Prophylaxis Resources DOSING ACROSS INDICATIONS Condition-specific dosing for XARELTO® RECORD1 Eriksson BI et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty ORS WELCOME KIT Your patient’s guide to starting treatment for ORS View all resources *Taken with evening meal. General Tags: DVT Prophylaxis: After hip/knee replacement surgery
